companydata.dkcompanydata.dk

AMPLEXA GENETICS A/S: Financial statements 2018

CVR: 29428441

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 906,955 and a net result of DKK -3,661,357 compared with DKK -2,969,411 the year before. That is an increase of 26.3% compared with the year before. Equity in the 2018 report amounted to DKK -28,908,860. The company had 7 employees in the financial year.

Gross Profit
DKK 906,955
Profit/Loss
DKK -3,661,357
Equity
DKK -28,908,860
Total Assets
DKK 5,257,385
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-907 t.-3.7 mio.-28.9 mio.7
2017-718 t.-3 mio.-25.2 mio.6
2016-440 t.-2.7 mio.-22.3 mio.-
2015-157 t.-3.4 mio.-19.6 mio.-
2014--186 t.-3.4 mio.-16.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

AMPLEXA GENETICS A/S: The 2017 annual report is outMay 15, 2018

AMPLEXA GENETICS A/S has published its annual report for 2017. Gross profit came to DKK 718,089, and the net result was DKK -2,969,411.

Leif Abrahamsen joins the board of AMPLEXA GENETICS A/SApr 24, 2018

As of April 24, 2018, Leif Abrahamsen has joined the board of directors of AMPLEXA GENETICS A/S.

Charles Steven Glavas joins the board of AMPLEXA GENETICS A/SApr 24, 2018

As of April 24, 2018, Charles Steven Glavas has joined the board of directors of AMPLEXA GENETICS A/S.

Pál Magni Weihe leaves the board of AMPLEXA GENETICS A/SApr 24, 2018

As of April 24, 2018, Pál Magni Weihe has left the board of directors of AMPLEXA GENETICS A/S.

Helle Hjalgrim joins AMPLEXA GENETICS A/S as adm. dir.Feb 1, 2018

As of February 1, 2018, Helle Hjalgrim is registered as adm. dir. of AMPLEXA GENETICS A/S.

Hans Atli Eli Albinus Dahl steps down as adm. dir. of AMPLEXA GENETICS A/SFeb 1, 2018

As of February 1, 2018, Hans Atli Eli Albinus Dahl has stepped down as adm. dir. of AMPLEXA GENETICS A/S.

About AMPLEXA GENETICS A/S

AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The board consists of Magnus Herdalur (chair), Eydfinn Reydberg and Ulf Bech Christensen. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.

Source: annual report 2025, Danish Business Authority